Wendeler M[au] - Search Results

Year	Number of Results
1989	2
1990	1
1991	1
2003	5
2004	4
2005	1
2006	4
2007	4
2008	3
2009	2
2010	3
2011	1
2012	1
2013	2
2014	3
2016	2
2017	3
2018	3
2019	1
2021	1
2022	0

1

Hexosaminidase assays.

Wendeler M, Sandhoff K. Wendeler M, et al. Glycoconj J. 2009 Nov;26(8):945-52. doi: 10.1007/s10719-008-9137-5. Glycoconj J. 2009. PMID: 18473163

2

Monitoring of antibody-drug conjugation reactions with UV/Vis spectroscopy.

Andris S, Rüdt M, Rogalla J, Wendeler M, Hubbuch J. Andris S, et al. Among authors: wendeler m. J Biotechnol. 2018 Dec 20;288:15-22. doi: 10.1016/j.jbiotec.2018.10.003. Epub 2018 Oct 12. J Biotechnol. 2018. PMID: 30321572

3

Chemical chaperones--a new concept in drug research.

Kolter T, Wendeler M. Kolter T, et al. Among authors: wendeler m. Chembiochem. 2003 Apr 4;4(4):260-4. doi: 10.1002/cbic.200390045. Chembiochem. 2003. PMID: 12672104 Review. No abstract available.

4

Using multimodal chromatography for post-conjugation antibody-drug conjugate purification: A methodology from high throughput screening to in-silico process development.

Keller WR, Wendeler M. Keller WR, et al. Among authors: wendeler m. J Chromatogr A. 2021 Sep 13;1653:462378. doi: 10.1016/j.chroma.2021.462378. Epub 2021 Jun 30. J Chromatogr A. 2021. PMID: 34311388

5

Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis.

Cao M, De Mel N, Jiao Y, Howard J, Parthemore C, Korman S, Thompson C, Wendeler M, Liu D. Cao M, et al. Among authors: wendeler m. MAbs. 2019 Aug/Sep;11(6):1064-1076. doi: 10.1080/19420862.2019.1624127. Epub 2019 Jun 14. MAbs. 2019. PMID: 31198090 Free PMC article.

6

Characterizing the Overall Derivatization of Conjugated Oligomeric Proteins.

Wendeler M, Zhao W, Thompson C, Baca M, Gadre D, Wang X, Yang H. Wendeler M, et al. PDA J Pharm Sci Technol. 2017 Mar-Apr;71(2):115-126. doi: 10.5731/pdajpst.2016.006510. Epub 2017 Mar 13. PDA J Pharm Sci Technol. 2017. PMID: 28289128

7

Multi-step high-throughput conjugation platform for the development of antibody-drug conjugates.

Andris S, Wendeler M, Wang X, Hubbuch J. Andris S, et al. Among authors: wendeler m. J Biotechnol. 2018 Jul 20;278:48-55. doi: 10.1016/j.jbiotec.2018.05.004. Epub 2018 May 4. J Biotechnol. 2018. PMID: 29733878

8

Camelid V_H H affinity ligands enable separation of closely related biopharmaceuticals.

Pabst TM, Wendeler M, Wang X, Bezemer S, Hermans P, Hunter AK. Pabst TM, et al. Among authors: wendeler m. Biotechnol J. 2017 Feb;12(2):1600357. doi: 10.1002/biot.201600357. Epub 2016 Oct 20. Biotechnol J. 2017. PMID: 27677057 Free PMC article.

9

Correlating SHAPE signatures with three-dimensional RNA structures.

Bindewald E, Wendeler M, Legiewicz M, Bona MK, Wang Y, Pritt MJ, Le Grice SF, Shapiro BA. Bindewald E, et al. Among authors: wendeler m. RNA. 2011 Sep;17(9):1688-96. doi: 10.1261/rna.2640111. Epub 2011 Jul 13. RNA. 2011. PMID: 21752927 Free PMC article.

10

Impact of Magnetic Stirring on Stainless Steel Integrity: Effect on Biopharmaceutical Processing.

Thompson C, Wilson K, Kim YJ, Xie M, Wang WK, Wendeler M. Thompson C, et al. Among authors: wendeler m. J Pharm Sci. 2017 Nov;106(11):3280-3286. doi: 10.1016/j.xphs.2017.07.008. Epub 2017 Jul 20. J Pharm Sci. 2017. PMID: 28734785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results